Home » Stocks » Ra Medical Systems

Ra Medical Systems, Inc. (RMED)

Stock Price: $0.430 USD -0.015 (-3.37%)
Updated Jul 9, 2020 9:48 AM EDT - Market open

Stock Price Chart

Key Info

Market Cap 14.89M
Revenue (ttm) 6.83M
Net Income (ttm) -49.98M
Shares Out 34.62M
EPS (ttm) -3.73
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 9, 2020
Last Price $0.430
Previous Close $0.445
Change ($) -0.015
Change (%) -3.37%
Day's Open 0.439
Day's Range 0.430 - 0.443
Day's Volume 423,303
52-Week Range 0.345 - 3.630

More Stats

Market Cap 14.89M
Enterprise Value n/a
Earnings Date (est) Nov 17, 2020
Ex-Dividend Date n/a
Shares Outstanding 34.62M
Float 9.66M
EPS (basic) -3.72
EPS (diluted) -3.73
FCF / Share -2.28
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 2.16M
Short Ratio 0.27
Short % of Float 7.33%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 2.18
PB Ratio 0.62
Revenue 6.83M
Operating Income -50.57M
Net Income -49.98M
Free Cash Flow -31.40M
Net Cash 20.10M
Net Cash / Share 0.58
Gross Margin -24.19%
Operating Margin -740.89%
Profit Margin -732.40%
FCF Margin -460.12%
ROA -59.87%
ROE -115.88%
ROIC -159.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (2)

Buy 1
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Overweight

Price Target

(248.84% upside)
Current: 0.430
Target: 1.50
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth15.06%6.59%-1.77%-
Gross Profit-1.652.051.712.84
Operating Income-57.73-31.16-17.76-4.20
Net Income-56.96-30.83-17.77-4.20
Shares Outstanding13.159.237.556.95
Earnings Per Share-4.33-3.34-2.35-0.60
Operating Cash Flow-33.17-18.51-5.52-1.89
Capital Expenditures-0.27-0.58-0.55-0.21
Free Cash Flow-33.44-19.09-6.07-2.10
Cash & Equivalents30.5864.328.243.92
Total Debt3.500.850.060.11
Net Cash / Debt27.0863.478.173.81
Book Value33.1566.71-7.62-0.38
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Ra Medical Systems, Inc.
Country United States
Employees 86
CEO Jonathan Will McGuire

Stock Information

Ticker Symbol RMED
Stock Exchange New York Stock Exchange
Sector Healthcare
Industry Medical Devices
Unique Identifier NYSE: RMED
IPO Date August 30, 2018


Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders. The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was founded in 2002 and is headquartered in Carlsbad, California.